A recently approved treatment is now available in the home.

BANNOCKBURN, Ill. (Sept. 6, 2017)—Option Care Enterprises, Inc., a provider of home and alternate treatment site infusion services, has signed an agreement to become a national contracted home infusion provider for RADICAVA (edaravone), an intravenous (IV) infusion treatment for amyotrophic lateral sclerosis (ALS). RADICAVA, the first ALS treatment option approved by the Food and Drug Administration (FDA) in more than 20 years, is now available for patient treatment in the United States.

OLD FORGE, Penn. (September 6, 2017)—Golden Technologies is pleased to announce a partnership with CareCredit, a provider of promotional health care financing, in order to offer Golden dealers a new financing solution. This collaboration will enable Golden dealers to help consumers acquire the medical equipment and supplies they need while easing the burden when insurance or reimbursements fall short.